Who is it for?
What's involved?
|
Registration Close Date
|
February 5th, 2026
|
|
Application Reviews Begin
|
January 31st, 2026
|
|
Elevate Workshop
|
February 26th–27th, 2026
|
We strongly recommend applying early to secure your spot, as applications will be considered on a first-come, first-serve basis and reviewed based on suitability and technological readiness.







.png?width=200&height=200&name=Mike%20Kulikov%20%20(1).png)
Nicholette Conway
Board Chair of Genetic Alliance Australia and Co- Founder and Director of AxisHealthCo.
With over 25 years of experience, Nicholette has worked across the pharmaceutical, medical device, and diagnostic industries. Her expertise spans clinical development (Phase 1-3), Health Technology Assessment (HTA) new product planning (NPP), market access, and reimbursement (MSAC & PBAC) and commercialisation, and is committed to delivering timely access to life changing treatments and improving health outcomes for patients through cross-disciplinary collaboration, building strong relationships and embracing new technologies.
Mike Kulikov
Customer Relationship Manager, Radium Capital.
Radium Capital is Australia’s leading R&D finance provider, Radium Capital powers Australian innovators by partnering with them to provide access to vital non-dilutive funding, resources, and connections. As Customer Relations Manager for NSW at Radium Capital, Mike Kulikov, PhD, talks daily with innovators, directors, and CFOs who are tackling some of the world’s biggest challenges. Before joining Radium Capital, Mike founded and led an EdTech start-up, gaining invaluable insights into entrepreneurship and the financial landscape for start-ups and scale-ups. He understands the complexities businesses face when trying to access funding and is passionate about supporting and helping innovative companies unlock their full potential by accessing their R&D tax refunds early.

Rebecca Dooley
Partner, Addisons
With nearly a decade’s experience in corporate and commercial law, Rebecca provides listed companies, SMEs, start ups and investors with legal advice relating to M&A and capital raising. Rebecca also provides legal advice on other corporate and commercial matters, including contracts, corporate governance and employee share plans.
Rebecca is well placed to help her clients given her thorough knowledge of Australian corporations law, contract law and the Australian Securities Exchange (ASX) Listing Rules. This knowledge is supplemented by an understanding of relevant market practice and trends, which enables Rebecca to help clients navigate both legal and commercial issues.
.png?width=200&height=200&name=Aleta%20Knowles%20(1).png)
Aleta Knowles
Investment Manager, Uniseed
Aleta brings extensive commercialisation, clinical research, and product development experience from the animal health industry where she has been involved in and led the development of pharmaceutical and biological products from discovery to product launch within large multinational companies. Her most recent role was leading the Clinical Research and Regulatory Affairs teams at Virbac where she was responsible for driving the strategy and implementation of Virbac’s innovation pipeline in Australia.
Often working at the nexus of university research and business, Aleta has held roles at UNSW and in industry that encompass external innovation, technology licensing, commercialisation, and technology transfer.
Located inside Westmead Health and Innovation District, The Cicada HealthTech Hub will be a home to early stage health companies, a space for collaboration and commercialisation activation, and a landing pad for industry seeking solutions to their research and business challenges. Helping to contribute to the vision of making Westmead a world-class innovation district in health and education.
